When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALRN - Early-stage study underway on Aileron's ALRN-6924 as myelopreservation agent
Aileron Therapeutics Inc.
The first participant has completed the initial cycle of treatment in a 120-subject Phase 1b/2 clinical trial evaluating Aileron Therapeutics' (ALRN+5.5%) ALRN-6924 as a myelopreservation agent in patients with p52 mutation-positive small cell lung cancer (SCLC) treated with the chemo agent topotecan.
More news on: Aileron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,